BackAkers Biosciences Overview

Akers Biosciences Long Term Debt

Latest long-term debt for AKER: $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer average

Loading

Akers Biosciences Long Term Debt History

Loading

Akers Biosciences vs. peers: Long Term Debt Comparison

Loading

Akers Biosciences Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Akers Biosciences (AKER) FAQ

Akers Biosciences (AKER) currently reports a long-term debt of $0 as of December 2020. In the prior-year period, the figure was $0. Use the charts on this page to explore Akers Biosciences's long-term debt history and peer comparisons.

Akers Biosciences's long-term debt changed from $0 to $0 (period ending December 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Akers Biosciences reported $0 in long-term debt as of December 2020. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Akers Biosciences, and consider following AKER for alerts when major investors trade the stock.

Akers Biosciences is classified in the Healthcare sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AKER with unrelated industries.